Tags

Type your tag names separated by a space and hit enter

Typhoid vaccination for international travelers from Greece visiting developing countries.
J Travel Med. 2014 Mar-Apr; 21(2):99-103.JT

Abstract

BACKGROUND

Typhoid fever is one of the most common diagnoses in returned international travelers. Our aim was to study the typhoid vaccine prescription practices for travelers from Greece visiting developing countries.

METHODS

A prospective questionnaire-based study was conducted during 2009-2012 in 57 Public Health Departments, which are the only sources of typhoid vaccine in Greece.

RESULTS

A total of 3,680 travelers were studied (median age: 38.1 years). Typhoid vaccine was delivered to 1,108 (30.1%) of them. Of those who traveled to sub-Saharan Africa, South America, the Middle East, the Indian subcontinent, Southeast Asia, South Africa, East Asia, North Africa, and Central America, 31.6, 17.1, 35, 44.2, 36.9, 31, 17.7, 31.6, and 36.8% received typhoid vaccine, respectively. Of travelers who stayed <1 month, 1 to <3 months, 3 to <6 months, and ≥6 months, 21.4, 63.1, 32.3, and 34.9% were vaccinated, respectively. According to the purpose of travel, typhoid vaccine was administered to 32.7% of those who traveled for leisure, to 28.8% of those who traveled for business, and to 24.1% of those visiting friends and relatives (VFRs). Of travelers who stayed in urban areas, rural areas, and urban and rural areas, 36.3, 30.1, and 26.8% were vaccinated, respectively. The majority of travelers who received the typhoid vaccine stayed in camps (62.9%) or at local residences (41%). Typhoid vaccine administration was statistically significantly associated with destination, duration of travel, purpose of travel, area of stay, and type of accommodation.

DISCUSSION

There is a need to increase awareness of travelers and public health professionals for typhoid vaccination and particularly for high-risk groups of travelers, such as travelers to the Indian subcontinent and VFRs. Strategies for continuing professional education should be developed for travel health professionals.

Authors+Show Affiliations

Travel Medicine Office; Department for Interventions in Health Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24251544

Citation

Smeti, Paraskevi, et al. "Typhoid Vaccination for International Travelers From Greece Visiting Developing Countries." Journal of Travel Medicine, vol. 21, no. 2, 2014, pp. 99-103.
Smeti P, Pavli A, Katerelos P, et al. Typhoid vaccination for international travelers from Greece visiting developing countries. J Travel Med. 2014;21(2):99-103.
Smeti, P., Pavli, A., Katerelos, P., & Maltezou, H. C. (2014). Typhoid vaccination for international travelers from Greece visiting developing countries. Journal of Travel Medicine, 21(2), 99-103. https://doi.org/10.1111/jtm.12076
Smeti P, et al. Typhoid Vaccination for International Travelers From Greece Visiting Developing Countries. J Travel Med. 2014 Mar-Apr;21(2):99-103. PubMed PMID: 24251544.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Typhoid vaccination for international travelers from Greece visiting developing countries. AU - Smeti,Paraskevi, AU - Pavli,Androula, AU - Katerelos,Panagiotis, AU - Maltezou,Helena C, Y1 - 2013/11/19/ PY - 2013/11/21/entrez PY - 2013/11/21/pubmed PY - 2014/11/14/medline SP - 99 EP - 103 JF - Journal of travel medicine JO - J Travel Med VL - 21 IS - 2 N2 - BACKGROUND: Typhoid fever is one of the most common diagnoses in returned international travelers. Our aim was to study the typhoid vaccine prescription practices for travelers from Greece visiting developing countries. METHODS: A prospective questionnaire-based study was conducted during 2009-2012 in 57 Public Health Departments, which are the only sources of typhoid vaccine in Greece. RESULTS: A total of 3,680 travelers were studied (median age: 38.1 years). Typhoid vaccine was delivered to 1,108 (30.1%) of them. Of those who traveled to sub-Saharan Africa, South America, the Middle East, the Indian subcontinent, Southeast Asia, South Africa, East Asia, North Africa, and Central America, 31.6, 17.1, 35, 44.2, 36.9, 31, 17.7, 31.6, and 36.8% received typhoid vaccine, respectively. Of travelers who stayed <1 month, 1 to <3 months, 3 to <6 months, and ≥6 months, 21.4, 63.1, 32.3, and 34.9% were vaccinated, respectively. According to the purpose of travel, typhoid vaccine was administered to 32.7% of those who traveled for leisure, to 28.8% of those who traveled for business, and to 24.1% of those visiting friends and relatives (VFRs). Of travelers who stayed in urban areas, rural areas, and urban and rural areas, 36.3, 30.1, and 26.8% were vaccinated, respectively. The majority of travelers who received the typhoid vaccine stayed in camps (62.9%) or at local residences (41%). Typhoid vaccine administration was statistically significantly associated with destination, duration of travel, purpose of travel, area of stay, and type of accommodation. DISCUSSION: There is a need to increase awareness of travelers and public health professionals for typhoid vaccination and particularly for high-risk groups of travelers, such as travelers to the Indian subcontinent and VFRs. Strategies for continuing professional education should be developed for travel health professionals. SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/24251544/Typhoid_vaccination_for_international_travelers_from_Greece_visiting_developing_countries_ L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1111/jtm.12076 DB - PRIME DP - Unbound Medicine ER -